**Background:** The review begins by framing human athletic performance within an evolutionary context, noting that bipedal locomotion and superior endurance capacity were essential for survival. Modern elite athletes represent an extreme phenotype, with maximal oxygen uptake (V̇O2max) values two- to threefold higher than untrained individuals (up to 96 mL/kg/min in males, 80 mL/kg/min in females). The authors emphasize that while exercise biology has advanced, many training programs for world-class athletes still rely on tradition rather than mechanistic science. The review aims to bridge the gap between training strategies, cellular adaptations, and molecular mechanisms for both endurance- and resistance-based exercise.
**Methods:** This is a narrative review that synthesizes literature across evolutionary biology, exercise physiology, cellular/molecular biology, and sports science. The authors discuss training principles (progressive overload, specificity, reversibility), periodization, and specific paradigms such as high-intensity interval training (HIIT), polarized training, altitude/hypoxic training, and training with low muscle glycogen. They then detail physiological adaptations (V̇O2max, cardiac output, muscle hypertrophy, fiber type distribution, mitochondrial density) and molecular mechanisms (Ca2+ signaling, AMPK, mTORC1, PGC-1α, mechanosensing, redox signaling, circadian clock interactions). Data are drawn from studies in untrained individuals, recreational athletes, and elite cohorts where available.
**Key Results:** Elite endurance athletes exhibit V̇O2max values of ~70–85 mL/kg/min (men) and ~60–75 mL/kg/min (women), with maximal stroke volumes of 150–200 mL/beat and cardiac outputs up to 30–40 L/min. Mitochondrial volume density is ~7.5–9% in elite athletes versus 4–5% in sedentary individuals, and citrate synthase activity is elevated by ~74%. Capillary-to-fiber ratio is 2.5–3 in athletes versus 1.5–2 in untrained. Type I fiber proportion exceeds 60% in endurance athletes, with extremes >90%. In strength/power athletes, type IIA fiber hypertrophy is predominant, with peak power outputs of 50–85 W/kg in countermovement jumps. The review notes that up to 20% of individuals may show low responsiveness to standardized training, but this can be overcome by increasing training volume/intensity. Genetic studies have identified >155 polymorphisms linked to elite performance, but effect sizes are small and replication is limited. The ACTN3 R577X polymorphism shows the most robust association: the 577R allele is enriched in sprint/power athletes, while the 577X variant is more common in endurance athletes.
**Clinical Implications:** The review underscores that the biology underlying exercise adaptation has direct clinical relevance. V̇O2max is a better predictor of morbidity and mortality than any other established risk factor. Relative muscle mass and strength similarly predict health outcomes. The molecular pathways activated by exercise—including AMPK, PGC-1α, and mitochondrial biogenesis—are targets for preventing and treating metabolic diseases, sarcopenia, and cardiovascular conditions. The authors caution against premature translation of 'exercise mimetics' (e.g., AMPK or PPARβ/δ activators) from animal models to humans, noting potential adverse effects and lack of performance benefit. They advocate for integrative, evidence-based approaches that combine mechanistic research with athlete feedback, and emphasize that insights from elite athletes can inform personalized exercise prescriptions for the general population and patient cohorts.